Jason Farley is a world-renowned nurse scientist and the inaugural Leadership and Innovation Endowed Chair at the Johns Hopkins University School of Nursing. He directs the Center for Infectious Disease and Nursing Innovation. As an Infectious Disease Nurse Epidemiologist and a Nurse Practitioner in the Division of Infectious Diseases at The Johns Hopkins School of Medicine, his clinical practice in the John Bartlett Specialty Practice spans HIV prevention, treatment and associated co-infections.
Dr. Farley’s research seeks to optimize a patient’s diagnostic experience, linkage to care, and their retention in care for a variety of infectious diseases. He designs multi-component interventions to build an equitable care experience tailored to the patient’s individual needs. Dr. Farley leads a cluster randomized trial [R01AI104488] designed to tailor nurse case management for persons with drug-resistant Tuberculosis and HIV co-infection in South Africa and a co-investigator on an adaptive, SMART trial [R01 NR016650], which involves an adaptive randomized evaluation of nurse-led HIV treatment and retention interventions for female sex workers living with HIV, also in South Africa. He and his team recently received a Discovery Award from Johns Hopkins University to conduct a randomized controlled trial to improve treatment adherence and retention in care for patients with TB and HIV co-infection using a combined community health worker armed with digital adherence technology to escalate adherence support in real-time.
Locally, in an interventional cohort in Baltimore City, his community health worker model offers an ‘unapologetically enabling’ approach to achieve equitable access, retention and engagement for patients struggling with HIV viral suppression. His team is responding directly to the COVID-19 pandemic and recently received multiple COVID-19 related grants, including 3 Coronavirus Prevention Network (CoVPN) grants and a collaborative supplement through the NIH Center for AIDS Research. C-Forward is a comparative effectiveness trial of COVID-19 testing modalities in which patients are randomized to hospital-based, mobile van or home-based COVID-19 testing [PIs: Farley (Nursing); Mehta (Public Health); and Jenning (Medicine)].
Dr. Farley earned his Ph.D. and his MSN at the Johns Hopkins School of Nursing, his MPH at the University of Alabama Birmingham (UAB), and his BSN at the University of Alabama (UA).